Imaging-Guided Bioreactor for Generating Bioengineered Airway Tissue
April 6th, 2022
The protocol describes an imaging-enabled bioreactor that allows the selective removal of the endogenous epithelium from the rat trachea and homogenous distribution of exogenous cells on the lumen surface, followed by long-term in vitro culture of the cell-tissue construct.
Overview
This protocol describes an imaging-enabled bioreactor for the selective removal of the endogenous epithelium from the rat trachea, facilitating the homogeneous distribution of exogenous cells on the lumen surface. The system allows for long-term in vitro culture and direct microscopic visualization of airway tissues during manipulation procedures.
Key Study Components
Area of Science
- Neuroscience
- Biotechnology
- Regenerative Medicine
Background
- Isolation of airway tissues is crucial for studying respiratory diseases.
- Imaging techniques enhance the monitoring of tissue manipulation.
- Bioengineered airway tissues can be used for disease modeling.
- Controlled removal of epithelium is essential for effective cell delivery.
Purpose of Study
- To develop a bioreactor for imaging-guided airway tissue manipulation.
- To enable the regeneration of airway tissues using exogenous cells.
- To facilitate drug screening and disease modeling.
Methods Used
- Construction of an imaging-enabled airway tissue bioreactor.
- Microscopic visualization during de-epithelization and cell delivery.
- In situ imaging for non-destructive monitoring of the tracheal lumen.
- Demonstration of the protocol by PhD students from the research group.
Main Results
- Successful removal of endogenous epithelium from rat trachea.
- Homogeneous distribution of exogenous cells achieved.
- Long-term culture of the cell-tissue construct demonstrated.
- Effective monitoring of airway tissue manipulation procedures.
Conclusions
- The imaging-enabled bioreactor is a valuable tool for airway tissue research.
- This method allows for precise control over tissue engineering processes.
- Potential applications in drug screening and modeling respiratory diseases.
Frequently Asked Questions
Executive Industry Relevance
Imaging-guided bioreactor platforms enable precise manipulation and monitoring of airway tissue constructs, supporting the development of physiologically relevant in vitro models for respiratory disease research. This capability enhances predictive confidence in drug screening and disease modeling by ensuring tissue integrity and reproducibility. Integration of real-time imaging with tissue engineering workflows addresses key inflection points in early discovery and translational research pipelines.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Facilitates controlled removal of endogenous airway epithelium for mechanistic de-risking.
- Enables direct visualization of tissue manipulation, supporting functional target validation.
- Supports hypothesis-driven interrogation of airway tissue responses to injury and regeneration.
Screening & Assay Development
- Prepares standardized, decellularized airway matrices for reproducible cell seeding and assay development.
- Provides quantitative imaging outputs for monitoring cell distribution and viability.
- Enables reliable evaluation of compound effects in engineered airway tissue systems.
Translational & Preclinical Research
- Aligns engineered airway constructs with disease-relevant tissue architecture for translational modeling.
- Maintains extracellular matrix integrity, supporting biomarker continuity from discovery to preclinical studies.
- Reduces biological risk by enabling non-destructive, longitudinal assessment of tissue constructs.
Pipeline & Workflow Integration
This imaging-guided bioreactor method bridges early discovery, assay development, and translational research by enabling real-time, quantitative monitoring of airway tissue engineering processes.
- Discovery Biology: Supports hypothesis testing and pathway clarification through controlled tissue manipulation and imaging.
- Screening: Delivers assay-ready, reproducible airway constructs with quantitative imaging outputs.
- Analytics: Provides real-time, non-destructive readouts for comparing cell seeding and tissue regeneration conditions.
- Translational Research: Ensures continuity of tissue architecture and biomarker relevance for preclinical validation.
- Enterprise Reuse: Establishes a reusable platform for generating and monitoring engineered airway tissues across multiple R&D programs.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in airway tissue engineering.
- Operational Value: Standardizes tissue preparation and monitoring, enhancing reproducibility and scalability.
- Strategic Value: Improves go/no-go decision-making and capital efficiency by enabling robust, quantitative tissue assessment.
- Portfolio Impact: Supports risk-adjusted prioritization and advancement of respiratory disease models and screening platforms.
Implementation Considerations
- Requires expertise in tissue engineering, imaging, and quantitative analysis.
- Needs specialized bioreactor hardware and real-time imaging instrumentation.
- Demands cross-team standardization of tissue preparation and imaging protocols.
- Adaptable to various airway tissue models with consideration for matrix and cell type compatibility.
- Dependent on maintenance of sterile conditions and precise control of culture parameters.
Biopharma FAQs
Chapters in this video
0:05
Introduction
1:14
Construction of Gradient Index (GRIN) Lens-Based Imaging Device
2:25
Imaging-Guided Removal of the Trachea Epithelium
5:51
Homogeneous Distribution of Exogenous Cells onto the Denuded Tracheal Lumen
8:23
Results: Imaging-Guided Bioreactors for the Generation of Functional In Vitro Airway Tissues
10:18
Conclusion
